HOME › DRUGS › CATRIDECACOG
ACTIVE SUBSTANCE / INN

CATRIDECACOG

Brand name(s): NovoThirteen
EMA LISTED
AUTHORISED
Blood Coagulation Disorders, Inherited
ACTIVE SUBSTANCE
Catridecacog
REGULATORS
EMA
SPONSORS / MAH
Novo Nordisk A/S
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NovoThirteenNovo Nordisk A/SAuthorised03/09/2012Blood Coagulation Disorders, Inherited

FULL INTELLIGENCE ON CATRIDECACOG

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →